Bicyclams, a class of potent anti-HIV agents, are targeted at the HIV coreceptor Fusin/CXCR-4
- 1 August 1997
- journal article
- Published by Elsevier in Antiviral Research
- Vol. 35 (3), 147-156
- https://doi.org/10.1016/s0166-3542(97)00025-9
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural GeneScience, 1996
- The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entryNature, 1996
- CC CKR5: A RANTES, MIP-1α, MIP-1β Receptor as a Fusion Cofactor for Macrophage-Tropic HIV-1Science, 1996
- The β-Chemokine Receptors CCR3 and CCR5 Facilitate Infection by Primary HIV-1 IsolatesCell, 1996
- Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8 + T CellsScience, 1995
- Highly potent and selective inhibition of human immunodeficiency virus by the bicyclam derivative JM3100Antimicrobial Agents and Chemotherapy, 1994
- Potent and selective inhibition of human immunodeficiency virus (HIV)-1 and HIV-2 replication by a class of bicyclams interacting with a viral uncoating event.Proceedings of the National Academy of Sciences, 1992
- Novel Sulfated Polysaccharides: Dissociation of Anti-Human Immunodeficiency Virus Activity from Antithrombin ActivityThe Journal of Infectious Diseases, 1990
- Long-term Persistent Infection of Macaque Monkeys with the Simian Immunodeficiency VirusJournal of General Virology, 1987
- The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirusNature, 1984